Neovacs SA (EURONEXT:ALNEV)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALNEV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALNEV

  • Market Cap€7.660m
  • SymbolEURONEXT:ALNEV
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0004032746

Company Profile

Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.Neovacs SA is a biotechnology company. The Company develops the next generation of therapeutic vaccines for autoimmune and inflammatory diseases like rheumatoid arthritis, Crohn's Disease and lupus (also called Systemic Lupus Erythematous or SLE).

Latest ALNEV news

Currently there for this company. Visit our news hub for other news .